Adamis Pharmaceuticals Corporation has announced the submission of a New Drug Application (NDA) to the FDA for its fast-dissolving sublingual...
Merck announced that the FDA has accepted for review the Biologics License Application (BLA) for MK-8237, Merck’s house dust mite...
This article reviews research advances for sublingual and patch immunotherapy for food allergy with a focus on peanut allergy. Published studies on sublingual immunotherapy (SLIT) and epicutaneous immunotherapy (EPIT) were summarized in this review.
The Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending the...
Braeburn Pharmaceuticals presented data from the Phase III study of Probuphine (subdermal buprenorphine implant) for the long-term maintenance treatment of...
Sunovion Pharmaceuticals Inc.has announced that it has submitted a new drug application (NDA) to the FDA on March 29, 2018,...
Insys Therapeutics, Inc. confirmed that an expert panel convened by the FDA voted not to recommend approval of the company�s...